Skip to content

Veracyte

US · VCYT #2330 by market cap Listed 1970
25.13 +0.09 +0.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 24.69 -1.40%
After-hours 25.18 +0.20%
Overnight 24.77 -1.08%
60.4924.0025.132026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on VCYT?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -39.2% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 11.9% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall B

The radar needs all six factors. Available grades are shown below.

Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 16.3x Better than 54%
Forward P/E 23.7x Better than 27%
Price / Sales 3.4x Better than 37%
P/E vs own 5-yr range 66th pctl Better than 43%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability B

How much profit the business keeps from each dollar of sales and capital.

Gross margin 70.1% Better than 83%
Operating margin 15.1% Better than 65%
Net margin 12.8% Better than 67%
Return on equity 5.3% Better than 38%
Return on invested capital 4.2% Better than 41%
Momentum D+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -40.6% Better than 10%
6-month return -44.2% Better than 10%
12-month return (ex latest month) 8.9% Better than 45%
Distance below 52-week high 58.7% Better than 11%
Financial Health A+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 8.1x Better than 92%
Debt to assets 2.8% Better than 85%
Interest coverage 68,202.0x Better than 100%
Free cash flow / net income 190.8% Better than 75%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 91.0% Better than 81%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +3.29%
1M -43.89%
3M -39.87%
6M -44.39%
YTD -40.31%
1Y -38.48%
3Y -3.49%
5Y -49.03%

Key statistics

Price & volume

Prev close
25.04
Open
24.63
Day range
24.53 - 25.60
Avg price
25.08
Volume
2.79M
Turnover
70.06M
Amplitude
4.27%
52-week range
21.91 - 60.91

Valuation

P/E
30.65
P/E (TTM)
16.32
P/B
1.41
EPS
0.82
Net profit
66.17M
Net assets
1.43B

Share structure

Market cap
2.03B
Float cap
2.02B
Shares out
80.70M
Float shares
80.19M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 8% of range
21.91 60.91

58.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-31.01M net over the window

Short interest

Shares short
9.56M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Veracyte (VCYT)?

Veracyte last traded at 25.13. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Veracyte's market cap?

About 2.03B.

What is the P/E ratio of Veracyte?

The trailing twelve-month P/E is 16.32. The Valuation tab shows it against the stock's own five-year range.

Does Veracyte pay a dividend?

Veracyte does not currently pay a regular dividend.

Is Veracyte a buy according to analysts?

The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 48.00, which implies 91.0% upside from the current price. This is not investment advice.

What is Veracyte's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Veracyte a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Veracyte discussion 0 comments

Add a comment